InvestSMART

Company announcements

leave blank for all companies
leave blank for all announcements
announcements
Reset Filters
~ We have limited the announcement data displayed on our website to the past 12 months to ensure its accuracy and usefulness.
Search Results
Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $1,586 Granted US patent for NNZ-2566 11 May 2006 11:48AM $0.550 $12.520 risen by 2,176.36%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $1,586 Commitments Test Entity - First Quarter Report 28 Apr 2006 1:25PM $0.575 $12.520 risen by 2,077.39%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $1,586 Neuren & US Army NNZ 2566 brain seizure results 26 Apr 2006 8:30AM $0.585 $12.520 risen by 2,040.17%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $1,586 Reports successful Phase 2 results 12 Apr 2006 9:02AM $0.605 $12.520 risen by 1,969.42%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $1,586 Preclinical results for oral administration of NNZ-2566 22 Mar 2006 8:45AM $0.590 $12.520 risen by 2,022.03%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $1,586 NNZ-2566 Phase 1 trial to commence 6 Mar 2006 8:31AM $0.570 $12.520 risen by 2,096.49%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $1,586 Preliminary Final Report 28 Feb 2006 9:05AM $0.570 $12.520 risen by 2,096.49%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $1,586 FDA pre-clinical requirements to Phase 3 completed 1 Feb 2006 11:07AM $0.530 $12.520 risen by 2,262.26%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $1,586 Commitments Test Entity - Fourth Quarter Report 31 Jan 2006 3:12PM $0.530 $12.520 risen by 2,262.26%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $1,586 Short Form Prospectus 2 Dec 2005 10:14AM n/a $12.520 n/a
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $1,586 Neuren raises $6.4 million in share placement 2 Dec 2005 8:54AM n/a $12.520 n/a
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $1,586 Reinstatement to Official Quotation 2 Dec 2005 8:53AM n/a $12.520 n/a
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $1,586 Suspension from Official Quotation 1 Dec 2005 8:48AM n/a $12.520 n/a
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $1,586 Trading Halt 29 Nov 2005 9:02AM n/a $12.520 n/a
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $1,586 Neuren Agreement with Jackson Foundation for Phase 3 24 Nov 2005 9:15AM $0.630 $12.520 risen by 1,887.30%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $1,586 Commitments Test Entity - Third Quarter Report 31 Oct 2005 2:41PM $0.690 $12.520 risen by 1,714.49%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $1,586 Response to ASX Share Price Query 3 Oct 2005 8:41AM $0.500 $12.520 risen by 2,404%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $1,586 Parkinsons & Hypertension patents issued 6 Sep 2005 12:05PM $0.400 $12.520 risen by 3,030%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $1,586 Half Yearly Report & Half Year Accounts 31 Aug 2005 2:43PM $0.390 $12.520 risen by 3,110.26%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $1,586 Neuren initiates Phase 2 trial 30 Aug 2005 9:54AM $0.420 $12.520 risen by 2,880.95%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $1,586 US Army Presents Neuren Research Results 24 Aug 2005 10:52AM $0.410 $12.520 risen by 2,953.66%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $1,586 Commitments Test Entity - Second Quarter Report 29 Jul 2005 1:16PM $0.435 $12.520 risen by 2,778.16%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $1,586 Walter Reed NNZ-2566 Contract Expanded 11 Jul 2005 8:30AM $0.470 $12.520 risen by 2,563.83%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $1,586 FDA advances Neuren to Phase 6 Jun 2005 8:30AM $0.415 $12.520 risen by 2,916.87%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
 Health Care $1,586 Admission to Official List 1 Feb 2005 4:03PM n/a $12.520 n/a

776 - 800 of 800 results

Page 32 of 32

  • + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.